Literature DB >> 2497703

Susceptibility to cephalosporins of penicillin-susceptible and penicillin-resistant strains of Neisseria gonorrhoeae from Philadelphia.

T Fekete1, D A Serfass, S C Lafredo, K R Cundy.   

Abstract

Using agar dilution, we determined MICs of penicillin, cefoxitin, ceftriaxone, cefmetazole, tetracycline, and spectinomycin for 129 strains of Neisseria gonorrhoeae. All strains were susceptible to ceftriaxone (MIC range, less than or equal to 0.008 to 0.06 micrograms/ml) and spectinomycin (16 to 32 micrograms/ml). The MICs for 50, 90, and 100% of strains tested were 1.0, 2.0, and greater than 8.0 micrograms/ml; 0.12, 1.0, and greater than 8.0 micrograms/ml; 0.5, 1.0, and 2.0 micrograms/ml; and 1.0, 2.0, and greater than 8.0 micrograms/ml for cefmetazole, penicillin, cefoxitin, and tetracycline, respectively. Seven strains were beta-lactamase producers; eight were chromosomally resistant to penicillin. There was a log-linear relation for non-beta-lactamase-producing strains between the MICs of cefmetazole, cefoxitin, and tetracycline and the MIC of penicillin (Pearson r = 0.787, 0.544, and 0.358, respectively).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497703      PMCID: PMC171449          DOI: 10.1128/AAC.33.2.164

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Frequency and distribution in the United States of strains of Neisseria gonorrhoeae with plasmid-mediated, high-level resistance to tetracycline.

Authors:  J S Knapp; J M Zenilman; J W Biddle; G H Perkins; W E DeWitt; M L Thomas; S R Johnson; S A Morse
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

2.  Genetic analysis and penicillin-binding protein alterations in Neisseria gonorrhoeae with chromosomally mediated resistance.

Authors:  T J Dougherty
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

3.  Chromosomally mediated resistance in Neisseria gonorrhoeae in the United States: results of surveillance and reporting, 1983-1984.

Authors:  R J Rice; J W Biddle; Y A JeanLouis; W E DeWitt; J H Blount; S A Morse
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

4.  Multiple antibiotic resistance due to a single mutation in Neisseria gonorrhoeae.

Authors:  M J Maness; P F Sparling
Journal:  J Infect Dis       Date:  1973-09       Impact factor: 5.226

5.  Single-dose aqueous procaine penicillin G therapy for gonorrhea: use of probenecid and cause of treatment failure.

Authors:  K K Holmes; W W Karney; J P Harnisch; P J Wiesner; M Turck; A H Pedersen
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

6.  Spectinomycin-resistant gonococcal infections in the United States, 1985-1986.

Authors:  J M Zenilman; L J Nims; M A Menegus; F Nolte; J S Knapp
Journal:  J Infect Dis       Date:  1987-12       Impact factor: 5.226

7.  Effects of different media and methods of inoculum preparation on results of antimicrobial susceptibility testing of Neisseria gonorrhoeae by agar dilution.

Authors:  J A Dillon; W Tostowaryk; M Pauzé
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

8.  Cefoxitin as a single-dose treatment for urethritis caused by penicillinase-producing Neisseria gonorrhoeae.

Authors:  S W Berg; M E Kilpatrick; W O Harrison; J A McCutchan
Journal:  N Engl J Med       Date:  1979-09-06       Impact factor: 91.245

9.  Ceftriaxone in the treatment of ordinary and penicillinase-producing strains of Neisseria gonorrhoeae.

Authors:  V S Rajan; E H Sng; T Thirumoorthy; C L Goh
Journal:  Br J Vener Dis       Date:  1982-10

Review 10.  Gonococcal infections.

Authors:  E W Hook; K K Holmes
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391

  10 in total
  4 in total

1.  Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline.

Authors:  R N Jones; T L Gavan; C Thornsberry; P C Fuchs; E H Gerlach; J S Knapp; P Murray; J A Washington
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

2.  Susceptibility of Neisseria gonorrhoeae to cefpodoxime: determination of MICs and disk diffusion zone diameters.

Authors:  T Fekete; J Woodwell; K R Cundy
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

Review 3.  Antimicrobial susceptibility testing of Neisseria gonorrhoeae and implications for epidemiology and therapy.

Authors:  T Fekete
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

4.  Interpretive criteria and quality control guidelines for Neisseria gonorrhoeae susceptibility test standardization for cefotetan.

Authors:  R N Jones; E H Gerlach; F P Koontz; P R Murray; M A Pfaller; J A Washington; M E Erwin; C C Knapp
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.